Home ivps4 2017-06-16T21:39:52+00:00

Investors Home

Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisinicline as a smoking cessation aid to address the global tobacco and nicotine addiction epidemic.

Stock Info

Recent Press Releases

Recent News

Feb 24, 2021

Achieve Life Sciences Announces Presentation of Data on Smoker and E-Cigarette User Attitudes and Perceptions on Quitting at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting

SEATTLE, Wash. and VANCOUVER, British Columbia, February 24, 2021 - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Feb 11, 2021

Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021

SEATTLE, Wash and VANCOUVER, British Columbia / ACCESSWIRE / February 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global...

Jan 7, 2021

Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

SEATTLE, Wash. and VANCOUVER, British Columbia, January 7, 2021 - - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...